What does this research mean for the field?

Genetic polymorphisms of the CYP2C9 gene affect the maintenance dose requirements for warfarin in patients undergoing anticoagulation therapy. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

December 1, 1995

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy

Structured PICO

Does genetic polymorphism of CYP2C9 affect warfarin maintenance dose requirement in patients undergoing anticoagulation therapy?

Population

Patients undergoing anticoagulation therapy

Intervention

CYP2C9 genetic polymorphism assessment

Outcome

Warfarin maintenance dose requirement

The study investigates the relationship between CYP2C9 genetic polymorphisms and warfarin maintenance dose requirements.

Abstract

Furuya, Hirokazu; Fernandez-Salguero, Pedro; Gregory, Wendy; Taber, Heather; Steward, Annette; Gonzalez, Frank J.; Idle, Jeffrey R. Author Information

AIに質問

Bookmark